InferVision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
InferVision, founded in January, 2016 and headquartered in Beijing, is an artificial intelligence medical system service provider. Established by Chen Kuan and Xia Chen, the company has received financings from CDH, Sequoia China, Haitong Kaiyuan and so on. Rivals that have direct and indirect competition with InferVision globally include AIdoc Medical, MedXT, Jianpei Technology, etc.
Cellatopia Secures Nearly CNY Ten Mn in Seed Funding
EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).
Apr 18, 2024 01:25 PM
AI Pharmaceutical R&D Company DP Technology Raises New Round of Over CNY 700 Mn Financing
EqualOcean has learned that DP Technology(深势科技), an AI pharmaceutical research company, has recently successfully completed a funding round of over CNY 700 million. Investors in this round include Zhongyuan Capital(众源资本), MSA Capital(和玉资本), Loyal Valley Capital(正心谷资本), Evergreen Scitech Delta(深势科技), and many other industry-specific investors, with Lighthouse Capital(光源资本) serving as the exclusive financial advisor.
Aug 22, 2023 03:34 PM